More

    Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet



    [
    Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet
    [og_img]
    https://www.investing.com/news/press-releases/akeso-announces-the-publication-of-its-phase-iii-clinical-trial-results-for-ivonescimab-in-headtohead-comparison-with-pembrolizumab-in-the-lancet-93CH-3914050


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img